Single-dose vaccine targets three respiratory viruses
Researchers have developed an experimental vaccine that provides simultaneous protection against three of the most dangerous respiratory viruses: seasonal influenza, coronavirus, and respiratory syncytial virus. Preliminary studies have shown that the vaccine successfully stimulated an immune response in mice and ferrets, with antibody levels comparable to those produced by individual vaccines. The vaccine is based on a unique technology involving spherical particles called "cobops," which differs from traditional coronavirus vaccines that are based on mRNA. Further studies are still needed to confirm its effectiveness in humans.
Size: 120%Text Size
Notice: This Is an AI-Generated Summary
Comments (0)